{"id":712,"date":"2019-06-18T09:30:18","date_gmt":"2019-06-18T07:30:18","guid":{"rendered":"https:\/\/www.comll.cat\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/"},"modified":"2019-06-18T09:30:18","modified_gmt":"2019-06-18T07:30:18","slug":"lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu","status":"publish","type":"post","link":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/","title":{"rendered":"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu"},"content":{"rendered":"<p>L\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu, excepci\u00f3 feta dels casos que sigui impossible un tractament alternatiu. L\u2019assaig cl\u00ednic <em>Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities<\/em>(CARES) realitzat amb aquest tipus de pacients mostra un augment significatiu del risc de mortalitat en malalts tractats amb febuxostat comparat amb pacients tractats amb al\u00b7lopurinol.<\/p>\n<p>CARES \u00e9s un estudi doble cec, aleatoritzat realitzat en m\u00e9s de 6.000 pacients amb gota i antecedents de malaltia cardiovascular o cerebrovascular. L\u2019objectiu va ser valorar el risc cardiovascular del tractament amb febuxostat en relaci\u00f3 amb el tractament amb al\u00b7lopurinol.<\/p>\n<p>La fitxa t\u00e8cnica i el prospecte del febuxostat s\u2019actualitzaran properament d\u2019acord amb els resultats del CARES.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular...<\/p>\n","protected":false},"author":1,"featured_media":430,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[18],"tags":[],"class_list":["post-712","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu - Col\u00b7legi Oficial de Metges de Lleida<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu - Col\u00b7legi Oficial de Metges de Lleida\" \/>\n<meta property=\"og:description\" content=\"L\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi Oficial de Metges de Lleida\" \/>\n<meta property=\"article:published_time\" content=\"2019-06-18T07:30:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/noticia-comll.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Albert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/\"},\"author\":{\"name\":\"Albert\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#\\\/schema\\\/person\\\/1c7bc4d83b35a927d680cfe0ec9120e0\"},\"headline\":\"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu\",\"datePublished\":\"2019-06-18T07:30:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/\"},\"wordCount\":160,\"image\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/noticia-comll.jpg\",\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/\",\"url\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/\",\"name\":\"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu - Col\u00b7legi Oficial de Metges de Lleida\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/noticia-comll.jpg\",\"datePublished\":\"2019-06-18T07:30:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#\\\/schema\\\/person\\\/1c7bc4d83b35a927d680cfe0ec9120e0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/noticia-comll.jpg\",\"contentUrl\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/noticia-comll.jpg\",\"width\":1280,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/\",\"name\":\"Col\u00b7legi Oficial de Metges de Lleida\",\"description\":\"COMLL\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.comll.cat\\\/es\\\/#\\\/schema\\\/person\\\/1c7bc4d83b35a927d680cfe0ec9120e0\",\"name\":\"Albert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g\",\"caption\":\"Albert\"},\"sameAs\":[\"https:\\\/\\\/www.comll.cat\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu - Col\u00b7legi Oficial de Metges de Lleida","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/","og_locale":"es_ES","og_type":"article","og_title":"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu - Col\u00b7legi Oficial de Metges de Lleida","og_description":"L\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular...","og_url":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/","og_site_name":"Col\u00b7legi Oficial de Metges de Lleida","article_published_time":"2019-06-18T07:30:18+00:00","og_image":[{"width":1280,"height":900,"url":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/noticia-comll.jpg","type":"image\/jpeg"}],"author":"Albert","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/#article","isPartOf":{"@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/"},"author":{"name":"Albert","@id":"https:\/\/www.comll.cat\/es\/#\/schema\/person\/1c7bc4d83b35a927d680cfe0ec9120e0"},"headline":"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu","datePublished":"2019-06-18T07:30:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/"},"wordCount":160,"image":{"@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/noticia-comll.jpg","articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/","url":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/","name":"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu - Col\u00b7legi Oficial de Metges de Lleida","isPartOf":{"@id":"https:\/\/www.comll.cat\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/#primaryimage"},"image":{"@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/noticia-comll.jpg","datePublished":"2019-06-18T07:30:18+00:00","author":{"@id":"https:\/\/www.comll.cat\/es\/#\/schema\/person\/1c7bc4d83b35a927d680cfe0ec9120e0"},"breadcrumb":{"@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/#primaryimage","url":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/noticia-comll.jpg","contentUrl":"https:\/\/www.comll.cat\/es\/wp-content\/uploads\/sites\/3\/noticia-comll.jpg","width":1280,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.comll.cat\/es\/lagencia-espanyola-dels-medicaments-desaconsella-lus-de-febuxostat-en-pacients-amb-gota-i-antecedents-de-patologia-cardiovascular-greu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.comll.cat\/es\/"},{"@type":"ListItem","position":2,"name":"L\u2019Ag\u00e8ncia Espanyola dels Medicaments desaconsella l\u2019\u00fas de febuxostat en pacients amb gota i antecedents de patologia cardiovascular greu"}]},{"@type":"WebSite","@id":"https:\/\/www.comll.cat\/es\/#website","url":"https:\/\/www.comll.cat\/es\/","name":"Col\u00b7legi Oficial de Metges de Lleida","description":"COMLL","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.comll.cat\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.comll.cat\/es\/#\/schema\/person\/1c7bc4d83b35a927d680cfe0ec9120e0","name":"Albert","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1261138a5e7882394bd9001104fe7078a2d860997555a5353af4ef7bd38f6db?s=96&d=mm&r=g","caption":"Albert"},"sameAs":["https:\/\/www.comll.cat"]}]}},"publishpress_future_action":{"enabled":false,"date":"2026-05-01 15:36:36","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/posts\/712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/comments?post=712"}],"version-history":[{"count":0,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/posts\/712\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/media\/430"}],"wp:attachment":[{"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/media?parent=712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/categories?post=712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.comll.cat\/es\/wp-json\/wp\/v2\/tags?post=712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}